| Schedule of company's other receivable balance |
| | | | | | | | | March 31, | | December 31, | | | 2026 | | 2025 | Grant income receivable: | | | | | | | CPRIT AML Grant | | $ | 1,054,666 | | $ | 815,436 | FDA Grant | | | 2,903 | | | 3,678 | SBIR AML Grant | | | 116,504 | | | 162,897 | Decoy Grant | | | 73,328 | | | 59,501 | SBIR NHL Grant | | | — | | | 87,417 | PANACEA Grant | | | 73,478 | | | 190,052 | Total grant income receivable | | | 1,320,879 | | | 1,318,981 | Interest receivable | | | 43,218 | | | 50,419 | Other | | | 13,203 | | | — | Total other receivable | | $ | 1,377,300 | | $ | 1,369,400 |
|